If youre a large employer that doesn't cover GLP-1s, heres something worth paying attention to from this fascinating article in The Wall Street Journal
Even if GLP-1 monotherapy is found to be less effective for opioid cessation than a combination therapy, it has the potential to reach vastly more patients and reach them at earlier stages, including the high percentage of patients who have refused existing medication options
690 Despite the potential benefits, challenges include data privacy concerns, the need for large and diverse datasets to train algorithms, and ensuring the transparency and interpretability of AI models remain
Sameday for Romania, GLS for most EU destinations, TCE Worldwide for the remaining cross-border EU and non-EU markets (UK, Switzerland, Iceland, Israel, Serbia)
The filing comes amid broader scrutiny of compounded GLP-1 products
Side effects: Muscle tissue is colored temporarily by this preparation